FEND TB Submission Form
We invite developers of TB diagnostics to submit proposals for the evaluation of early-stage TB diagnostics and novel testing strategies. For any questions, contact us at fendtech@rutgers.edu.
The most recent TB diagnostics submission cycle is now closed. We will begin accepting applications again on July 1, 2026.
Requesting a CDA is optional and will delay the review process.
Please populate the PowerPoint template provided above. You will be prompted to submit the presentation on the final page of the submission form.
Cycle 19 Submissions will be open from July 1, 2026 to September 30, 2026
FEND-TB Conflict of Interest Disclaimer
The Feasibility of Novel Diagnostics for TB in Endemic Countries (FEND-TB) program, led by Rutgers University in collaboration with multiple global partners, includes investigators who may have research-related relationships with diagnostic manufacturers. These relationships may involve receipt of research support, equipment, reagents, or other resources provided for independent evaluation under appropriate institutional oversight.
All FEND-TB evaluations are conducted according to established scientific and ethical standards, with full adherence to institutional conflict-of-interest policies and procedures. The presence of such relationships does not influence the objectivity, integrity, or independence of the evaluation process.